🇺🇸 FDA
Patent

US 8729115

Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases

granted A61PA61P3/00A61P3/10

Quick answer

US patent 8729115 (Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases) held by CARDIOLYNX AG expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CARDIOLYNX AG
Grant date
Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P3/00, A61P3/10, A61P9/00, A61P9/10